๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Secondary acute myelogenous leukemia following treatment with oral etoposide

โœ Scribed by Katato, Khalil; Flaherty, Lawrence; Varterasian, Mary

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
246 KB
Volume
53
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Secondary acute promyelocytic leukemia a
Secondary acute promyelocytic leukemia after treatment with etoposide for langerhans cell histiocytosis (LCH)
โœ Lopes, Luiz Fernando; de Camargo, Beatriz ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 24 KB ๐Ÿ‘ 2 views

To the Editor: We here describe a 3-year-old-boy who was treated for LCH using vinblastine, etoposide and prednisone according to the International Langerhans Cell Histiocytosis Study I. The patient was admitted in March 1993 with multiple bone lesions, diabetes insipidus and biopsy confirmed LCH. H

Therapeutic leukapheresis in patients wi
Therapeutic leukapheresis in patients with leukostasis secondary to acute myelogenous leukemia
โœ Gil Cunha De Santis; Luciana Correa Oliveira de Oliveira; Lucas Gabriel Maltoni ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 98 KB

## Abstract Leukostasis is a relatively uncommon but potentially catastrophic complication of acute myelogenous leukemia (AML). Prompt leukoreduction is considered imperative to reduce the high mortality rate in this condition. Leukapheresis, usually associated with chemotherapy, is an established